BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9642464)

  • 1. [Human African trypanosomiasis, contributions of experimental models].
    Bouteille B; Millet P; Enanga B; Mezui Me J; Keita M; Jauberteau MO; Georges A; Dumas M
    Bull Soc Pathol Exot; 1998; 91(2):127-32. PubMed ID: 9642464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma brucei brucei: a long-term model of human African trypanosomiasis in mice, meningo-encephalitis, astrocytosis, and neurological disorders.
    Keita M; Bouteille B; Enanga B; Vallat JM; Dumas M
    Exp Parasitol; 1997 Feb; 85(2):183-92. PubMed ID: 9030668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human African trypanosomiasis].
    Dumas M; Bouteille B
    C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and neuropathogenesis issues in human African trypanosomiasis.
    Kennedy PG
    Int J Parasitol; 2006 May; 36(5):505-12. PubMed ID: 16546191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megazol combined with suramin improves a new diagnosis index of the early meningo-encephalitic phase of experimental African trypanosomiasis.
    Darsaud A; Chevrier C; Bourdon L; Dumas M; Buguet A; Bouteille B
    Trop Med Int Health; 2004 Jan; 9(1):83-91. PubMed ID: 14728611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vervet monkey (Chlorocebus aethiops) as an experimental model for Trypanosoma brucei gambiense human African trypanosomiasis: a clinical, biological and pathological study.
    Ouwe-Missi-Oukem-Boyer O; Mezui-Me-Ndong J; Boda C; Lamine I; Labrousse F; Bisser S; Bouteille B
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):427-36. PubMed ID: 16325877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei-infected mice.
    Hunter CA; Jennings FW; Kennedy PG; Murray M
    Lab Invest; 1992 Nov; 67(5):635-42. PubMed ID: 1434541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An efficacy trial on Trypanosoma brucei brucei of molecules permeating the blood-brain barrier and of megazol].
    Marie-Daragon A; Rouillard MC; Bouteille B; Bisser S; de Albuquerque C; Chauvière G; Périé J; Dumas M
    Bull Soc Pathol Exot; 1994; 87(5):347-52. PubMed ID: 7496199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis.
    Lejon V; Roger I; Mumba Ngoyi D; Menten J; Robays J; N'siesi FX; Bisser S; Boelaert M; Büscher P
    Clin Infect Dis; 2008 Jul; 47(1):15-22. PubMed ID: 18494605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis.
    Rodgers J; Bradley B; Kennedy PG
    Parasitol Int; 2007 Dec; 56(4):321-4. PubMed ID: 17643344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
    Legros D; Fournier C; Gastellu Etchegorry M; Maiso F; Szumilin E
    Bull Soc Pathol Exot; 1999 Jul; 92(3):171-2. PubMed ID: 10472443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
    Ngotho M; Kagira JM; Kariuki C; Maina N; Thuita JK; Mwangangi DM; Farah IO; Hau J
    Acta Trop; 2011 Jul; 119(1):14-8. PubMed ID: 21420376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma kinetics and efficacy of oral megazol treatment in Trypanosoma brucei brucei-infected sheep.
    Boda C; Enanga B; Dumet H; Chauviere G; Labrousse F; Couquet C; Saivin S; Houin G; Perie J; Dumas M; Bouteille B
    Vet Parasitol; 2004 May; 121(3-4):213-23. PubMed ID: 15135860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy against human African trypanosomiasis: is there a road to success?
    Burri C
    Parasitology; 2010 Dec; 137(14):1987-94. PubMed ID: 20961469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of megazol on Trypanosoma brucei brucei acute and subacute infections in Swiss mice.
    Bouteille B; Marie-Daragon A; Chauvière G; de Albuquerque C; Enanga B; Dardé ML; Vallat JM; Périé J; Dumas M
    Acta Trop; 1995 Oct; 60(2):73-80. PubMed ID: 8610542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of experimental trypanosomiasis of sheep caused by Trypanosoma brucei brucei: efficacy of Ro 15-0216 (a 2-nitroimidazole derivative)].
    Bouteille B; Darde ML; Pestre-Alexandre M; Dumas M; Breton JC; Nicolas JA; Catanzano G; Munoz M
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):616-22. PubMed ID: 3197255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The detection of anti-galactocerebroside autoantibodies in human African trypanosomiasis].
    Jauberteau PM; Bisser S; Ayed Z; Brindel I; Bouteille B; Stanghellini A; Gampo S; Doua F; Breton JC; Dumas M
    Bull Soc Pathol Exot; 1994; 87(5):333-6. PubMed ID: 7496196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness.
    Buguet A; Bisser S; Josenando T; Chapotot F; Cespuglio R
    Acta Trop; 2005 Jan; 93(1):107-17. PubMed ID: 15589803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.